GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $47,000 | -2.1% | 21,677 | +0.3% | 0.00% | – |
| Q4 2020 | $48,000 | -18.6% | 21,619 | -2.8% | 0.00% | – |
| Q3 2020 | $59,000 | -15.7% | 22,241 | -2.2% | 0.00% | – |
| Q2 2020 | $70,000 | +52.2% | 22,746 | -4.1% | 0.00% | – |
| Q1 2020 | $46,000 | -36.1% | 23,712 | -5.5% | 0.00% | – |
| Q4 2019 | $72,000 | -22.6% | 25,082 | -0.8% | 0.00% | – |
| Q3 2019 | $93,000 | +9.4% | 25,294 | +23.3% | 0.00% | – |
| Q2 2019 | $85,000 | -100.0% | 20,506 | -94.1% | 0.00% | -100.0% |
| Q1 2016 | $500,000,000 | +12.9% | 349,425 | +29.5% | 0.00% | 0.0% |
| Q4 2015 | $443,000,000 | +79433.2% | 269,925 | +13.4% | 0.00% | 0.0% |
| Q3 2015 | $557,000 | -99.9% | 237,925 | +22.9% | 0.00% | 0.0% |
| Q2 2015 | $528,596,000 | -9.4% | 193,625 | +11.2% | 0.00% | 0.0% |
| Q1 2015 | $583,241,000 | +1263.5% | 174,102 | +1312.4% | 0.00% | – |
| Q4 2014 | $42,775,000 | -27.8% | 12,327 | +4.7% | 0.00% | – |
| Q3 2014 | $59,228,000 | -63.6% | 11,775 | -0.1% | 0.00% | -100.0% |
| Q2 2014 | $162,737,000 | – | 11,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 129,488 | $271,925 | 0.08% |
| Geneos Wealth Management Inc. | 427,400 | $897,540 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $25,200 | 0.02% |
| Vivaldi Capital Management LP | 19,261 | $40,448 | 0.01% |
| Beacon Capital Management, LLC | 12,605 | $26,471 | 0.01% |
| Atria Wealth Solutions, Inc. | 263,300 | $552,930 | 0.01% |
| Wealthspire Advisors, LLC | 183,862 | $386,111 | 0.01% |
| BARRETT & COMPANY, INC. | 4,984 | $10,466 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,271,760 | $2,670,656 | 0.01% |
| Ameritas Advisory Services, LLC | 45,302 | $94,856 | 0.01% |